MedPath
HSA Approval

ALMIRAL TABLET 50 mg

SIN06172P

ALMIRAL TABLET 50 mg

ALMIRAL TABLET 50 mg

May 20, 1991

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

M01AB05

diclofenac

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD

Active Ingredients

DICLOFENAC SODIUM

50 mg

Diclofenac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALMIRAL TABLET 50 mg - HSA Approval | MedPath